Skip to main content
Journal of Family Medicine and Primary Care logoLink to Journal of Family Medicine and Primary Care
. 2023 Feb 15;12(1):101–105. doi: 10.4103/jfmpc.jfmpc_834_22

Evaluation of treatment response results in patients with normal-pressure hydrocephalus undergoing surgery

Khalil Komlakh 1, Hamidreza Oveisi 3, Seyed Hossein Aghamiri 2,
PMCID: PMC10071903  PMID: 37025224

ABSTRACT

Introduction:

Endoscopic third ventriculostomy is an important surgical method in the treatment of various forms of adult hydrocephalus and in many cases is more effective than traditional methods. The aim of this study was to evaluate the results of response to treatment in patients with normal-pressure hydrocephalus undergoing endoscopic third ventriculostomy surgery.

Materials and Methods:

This descriptive cross-sectional study was performed on 24 patients with normal-pressure hydrocephalus who underwent endoscopic third ventriculostomy. The patients were selected by the available sampling method, and the data were collected through a researcher-made checklist. Data were analyzed using SPSS-26 software.

Results:

Among 24 patients, 62.5% were male and the mean age was 70.85 ± 9.1 years. The results showed that there was no statistically significant relationship between age (P value = 0.43) and sex (P value = 0.37) with the success and failure rate of the surgical method. There was a significant difference between movement disorders (P value = 0.00) and dementia (P value = 0.00) before and after surgery, while there was no statistically significant difference between urinary disorders before and after surgery (P value = 0.22).

Discussion and Conclusion:

Endoscopic third ventriculostomy is an effective surgical method in the treatment of patients with normal-pressure hydrocephalus and it improves the symptoms of movement disorder and dementia.

Keywords: Dementia, disorder, endoscopic third ventriculostomy, hydrocephalus

Introduction

Hydrocephalus (HCP) can be defined as an abnormal accumulation of cerebrospinal fluid (CSF) in the ventricles of the brain resulting in increased intracranial pressure, and if the onset occurs during childhood, it can lead to an abnormal increase in head circumference of the newborn.[1] The disease is characterized by three clinical signs; gait and balance disorders are the most important symptoms, while with the progression of the disease, cognitive decline and urinary incontinence appear.[2] Gait and balance disorders are a combination of movement disorders, loss of correct postural reflexes, abnormal pursuit, and failure to suppress vestibulo-ocular reflexes.[3] Normal-pressure hydrocephalus is a chronic disease observed in adults. The disease manifests as Adams–Hakim syndrome with a triad of urinary incontinence, cognitive impairment and gait imbalance. In these patients, imaging findings show that the ventricles of the brain are dilated, but according to lumbar puncture, the CSF pressure is normal.[4]

In general, ventriculoperitoneal shunting is the first option for the treatment of normal-pressure HCP; however, it has several complications, including shunt infection, excessive drainage, and shunt dysfunction such as obstruction, which may require surgical intervention or drug treatment.[5] Thus, the rate of shunt retention for 1 and 2 years was reported to be 61% and 47%, respectively. On the other hand, since ventriculoperitoneal shunting reduces the size of dilated ventricles, it may lead to ventricular rupture syndrome, which is associated with more complications if re-shunting is required.[4] Endoscopic third ventriculostomy (ETV) is a new method for the treatment of HCP in which, in addition to the fact that the patient does not need an implant, the risk of infection is low and the long-term treatment outcomes are observed to be excellent.[6] Numerous studies indicate the predominant effect of ETV in pediatric and adult patients, but considering the importance of treatment outcomes in these patients and the limited information on the treatment outcomes in the country, evaluation of the possibility of failure and response to treatment in normal-pressure HCP patients undergoing ETV is essential.[7] Thus, the present study aimed to investigate the results of response to treatment in patients with normal-pressure HCP undergoing ETV surgery.

Materials and Methods

Study method and study population

The present study is a retrospective descriptive cross-sectional study with practical objectives that was conducted from 2017 to 2021 in Imam Hossein Hospital, affiliated with Shahid Beheshti University of Medical Sciences in Tehran. The study population in this research included all patients with normal-pressure HCP who were referred to Imam Hossein Hospital in Tehran between 2017 and 2021 and underwent ETV.

Sampling and volume of the statistical population studied

The available sampling method was implemented. Thus, all patients who underwent ETV surgery were included in the study. In this study, the sample size was estimated to be equal to 24 people.

Inclusion and exclusion criteria

Inclusion criteria included patients older than 50 years of age with normal-pressure HCP who underwent ETV. Exclusion criteria included patients who had conflicting information or lack of communication, patients who were unwilling to cooperate and participate in the study, and cases that were less than 50 years old.

Data collection method

The data collection tool was a researcher-made checklist that included questions related to demographic characteristics, symptoms of patients, such as HCP triad which included gait disorders, memory and dementia disorders, and urinary disorders before and after surgery, and the outcomes of treatment of patients. The content validation method was used to evaluate the validity of the data collection tool. In this way, by studying books, magazines, domestic and foreign publications, using electronic databases, using the opinions of physicians and nurses of the neurosurgery department, and supervisors and consultants, a research checklist was prepared and then based on the views of 10 neurology professors and surgeons of Shahid Beheshti University of Medical Sciences, the necessary corrections were made to the checklist, and thus the data collection tool was confirmed in terms of validity.

Study method

The present study is a retrospective descriptive cross-sectional study with practical objectives that was conducted from 2017 to 2021 in Imam Hossein Hospital, affiliated with Shahid Beheshti University of Medical Sciences in Tehran, and the study population included all patients with normal-pressure HCP who underwent ETV.

A total of 24 patients, who met the inclusion criteria, were entered into the study after receiving informed consent. After submitting the proposal to the Research Committee and the Ethics Committee of the Medical School of Shahid Beheshti University of Medical Sciences in Tehran and obtaining the necessary permits to collect the required information and data, the questionnaires were completed by patients. Patients were assured that all their information would remain strictly confidential. After completing the questionnaires, the collected information was analyzed using statistical methods.

Data analysis method

Mean and standard deviation of numerical variables and quantity and percentage of qualitative variables were reported in each group, and these data were analyzed and compared using paired T-test and Pearson’s Chi-squared test, respectively. SPSS 26 software was used to analyze the data.

Ethical considerations

Participation in this study was completely voluntary, and written consent was obtained from all studied individuals. Also, the information of the participants would remain completely confidential.

Results

The results showed that among 24 patients studied, 15 were male (62.5%) and 9 (37.5%) were female. The mean age of patients was 70.58 years with a standard deviation of 9.1 years. The minimum age was 54 years and the maximum age was 84 years. Also, among the patients, 21 patients had symptoms of cognitive impairment and dementia before surgery and 3 patients did not have these symptoms. Also, 23 patients had symptoms of gait disorder before surgery and 1 person did not show these symptoms. Among the subjects, 8 patients had symptoms of urinary disorders before surgery and 16 patients did not have these symptoms [Table 1].

Table 1.

Frequency distribution of samples based on the studied variables, before and after surgery

Variable Before surgery Frequency (%) After surgery Frequency (%)
Memory and dementia disorders No 3 (12.5) No recovery 13 (61.9)
Yes 21 (87.5) Partial recovery 6 (28.6)
Full recovery 2 (9.5)
Movement disorders No 1 (4.2) No recovery 8 (34.8)
Yes 23 (95.8) Partial recovery 10 (43.5)
Full recovery 5 (21.7)
Urinary disorders No 16 (66.7) No recovery 6 (75)
Yes 8 (33.3) Partial recovery 1 (12.5)
Full recovery 1 (12.5)
Final response to treatment after surgery No recovery 9 (29.2)
Partial recovery 12 (50)
Full recovery 5 (20.8)

According to Table 1, among 21 patients in the study who had symptoms of memory impairment and dementia before surgery, 2 patients recovered completely and 6 patients recovered partially after surgery, while 13 patients were not significantly improved. Also, out of 23 patients with movement disorders, 2 patients have fully recovered and 6 patients had partial recovery after surgery, while 13 patients were not significantly improved. On the other hand, among 8 patients participating in the study who had symptoms of urinary disorders before surgery, 1 patient completely recovered after surgery and 1 patient partially recovered, while 6 patients were not significantly improved. Out of 24 patients participating in the study, 4 patients (16.7%) required re-shunting after surgery and 20 patients (83.3%) did not require re-shunting. The results also showed that among 4 patients who needed re-shunting after surgery, in 2 patients this need was observed after 3 months, for 1 patient it was found after 6 months, and in 1 patient, the need for re-shunting was observed more than 1 year after surgery. The mean of this duration was 9 months with a standard deviation of 10 months. The minimum time was 3 months and the maximum time was 24 months after surgery.

Data analysis using the Chi-square test showed no statistically significant relationship between the age of patients with the variables of memory and dementia disorders, movement disorders, and urinary disorders, before and after surgery. It was also shown that there was no statistically significant relationship between the age of patients and the rate of response to treatment [Table 2].

Table 2.

Evaluation of the relationship between the age of patients and the studied variables, before and after surgery

First variable Second variable Chi-square df P
Age Dementia disorders before surgery 17.9 17 0.39*
Dementia disorders after surgery 29.8 32 0.57
Movement disorders before surgery 7.3 17 0.97
Movement disorders after surgery 33.9 34 0.47*
Urinary disorders before surgery 21 17 0.22*
Urinary disorders after surgery 16 10 0.10*
Final response to treatment 34.6 34 0.43*

*Statistical significance with P≤0.5

The analysis of data using the Chi-square test demonstrated that there was no statistically significant relationship between the gender of patients with the variables of memory and dementia disorders, movement disorders, and urinary disorders, before and after surgery. It was also shown that there was no statistically significant relationship between the gender of patients and the rate of response to treatment [Table 3].

Table 3.

Evaluation of the relationship between the gender of patients and the studied variables, before and after surgery

First variable Second variable Chi-square df P
Gender Dementia disorders before surgery 0.02 1 0.87
Dementia disorders after surgery 4.4 2 0.11*
Movement disorders before surgery 1.73 1 0.18*
Movement disorders after surgery 0.18 2 0.91
Urinary disorders before surgery 0.8 1 0.37*
Urinary disorders after surgery 2 2 0.36*
Final response to treatment 1.96 2 0.37*

*Statistical significance with P≤0.5

Data analysis using paired t-test showed that there was a significant difference between memory and dementia disorders, as well as movement disorders, before and after surgery, while there was no statistically significant difference between urinary disorders before and after surgery [Table 4].

Table 4.

Data analysis using paired t-test

Variable Mean difference before and after surgery t df P
Dementia disorders 0.47 3.2 20 0.00*
Movement disorders 0.86 5.5 22 0.00*
Urinary disorders 0.50 1.3 7 0.22*

*Statistical significance with P≤0.5

Discussion

Despite significant advances in neurosurgery techniques, deciding on the most effective treatment for HCP, especially first-line surgical intervention, is still controversial given the failure rate and complications of each approach.[8] ETV is an alternative method to ventriculoperitoneal shunting, and the use of this method raises the question of which patients would benefit most from this procedure.[9] In 2017, a study was conducted by Mersha et al.[10] in Addis Ababa, Ethiopia. In this research, the use of ETV in children with obstructive HCP was evaluated in comparison with ventriculoperitoneal shunting. A percentage of 25.9 (67 people) of the patients underwent surgery with ETV and 74.1% (192 people) of the patients underwent ventriculoperitoneal shunting. In this study, the rate of postoperative infection in patients undergoing ventriculoperitoneal shunting was significantly higher than in patients undergoing ETV (27% vs. 6.1%). Also, the rate of complications following the ETV method was 12%, and in patients who underwent ventriculoperitoneal shunting, this rate was 27%, and the difference was statistically significant.[10] The rate of treatment failure one year after surgery was 45.3% in the ventriculoperitoneal shunting group, and 38.8% in the ETV group, but the difference was not statistically significant.

In 2014, another study was conducted by Linnea Torsnes et al. in Norway, and the efficacy of different therapeutic methods for patients with normal-pressure HCP was investigated. The findings demonstrated that ETV was less successful than shunting, and ETV was not the preferred method of treatment for HCP patients, which was in contradiction with the results of our study.[11] The results of the present study showed that the symptoms of HCP triad, including dementia and memory disorders, were present in 87.5% of patients, movement disorders were present in 95.8% of patients, and urinary disorders were observed in 33.3% of patients. In a study by Larsson et al.,[12] the total percentage of HCP triad symptoms was reported to be 50–75%, movement disorders between 80% and 95%, and urinary disorders were reported to be 50–75%, which is consistent with the results of our study. In 2013 Neils et al.[13] showed that the success rate of ETV surgery varies between 67% and 80%. They also showed that most failures of this procedure occur within 30 days after surgery, which are usually associated with CSF leaks from the wounds. In addition, in a study by Sand Lam et al.,[14] it was stated that in 76% of patients who underwent unsuccessful ETV, ventriculoperitoneal shunting was used again, and in our study, this rate was equal to 57%. The results of our study showed that the failure rate of ETV was 29.2%, which is in line with the findings of Mersha et al.;[10] they reported the failure rate to be 38.8%. In the present study, the results of data analysis showed that the age and gender of patients had no significant relationship with the failure rate of ETV surgery, which was consistent with the results of the study by Mersha et al. However, in a study by Drake et al.,[15] a significant relationship was observed between the age of patients and the success rate of ETV surgery.

One of the limitations of this study was the small size of the study population. On the other hand, considering that the complications of ETV can be seen after 1 year, one of the strengths of this study was the duration of follow-up of patients, which was performed for 1 year.

Conclusion

ETV is an effective surgical procedure in the treatment of patients with normal-pressure HCP that can improve movement disorders and dementia.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurol India. 2009;57:368–74. doi: 10.4103/0028-3886.55572. [DOI] [PubMed] [Google Scholar]
  • 2.Kang YS, Park EK, Kim JS, Kim DS, Thomale UW, Shim KW. Efficacy of endoscopic third ventriculostomy in old aged patients with normal pressure hydrocephalus. Neurol Neurochir Pol. 2018;52:29–34. doi: 10.1016/j.pjnns.2017.10.004. [DOI] [PubMed] [Google Scholar]
  • 3.Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, et al. Deconstructing normal pressure hydrocephalus:Ventriculomegaly as early sign of neurodegeneration. Ann Neurol. 2017;82:503–13. doi: 10.1002/ana.25046. [DOI] [PubMed] [Google Scholar]
  • 4.Mongin M, Hommet C, Mondon K. [Normal pressure hydrocephalus:A review and practical aspects. Rev Med Interne. 2015;36:825–33. doi: 10.1016/j.revmed.2015.08.001. [DOI] [PubMed] [Google Scholar]
  • 5.Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, et al. Guidelines for management of idiopathic normal pressure hydrocephalus:Second edition. Neurol Med Chir (Tokyo) 2012;52:775–809. doi: 10.2176/nmc.52.775. [DOI] [PubMed] [Google Scholar]
  • 6.Ivkovic M, Reiss-Zimmermann M, Katzen H, Preuss M, Kovanlikaya I, Heier L, et al. MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2015;12:9. doi: 10.1186/s12987-015-0004-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Jaraj D, Rabiei K, Marlow T, Jensen C, Skoog I, Wikkelsø C. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014;82:1449–54. doi: 10.1212/WNL.0000000000000342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hailong F, Guangfu H, Haibin T, Hong P, Yong C, Weidong L, et al. Endoscopic third ventriculostomy in the management of communicating hydrocephalus:A preliminary study. J Neurosurg. 2008;109:923–30. doi: 10.3171/JNS/2008/109/11/0923. [DOI] [PubMed] [Google Scholar]
  • 9.Baldauf J, Fritsch MJ, Oertel J, Gaab MR, Schröder H. Value of endoscopic third ventriculostomy instead of shunt revision. Minim Invasive Neurosurg. 2010;53:159–63. doi: 10.1055/s-0030-1268415. [DOI] [PubMed] [Google Scholar]
  • 10.Jesmani M A, Ranjbar Hameghavandi M H, Khoshnevisan A. Comparison of failure between post- shunted ETV and primary ETV in hydrocephalus:a review article. RJMS. 2019;26:37–45. [Google Scholar]
  • 11.Torsnes L, Blåfjelldal V, Poulsen FR. Treatment and clinical outcome in patients with idiopathic normal pressure hydrocephalus –A systematic review. Dan Med J. 2014;61:A4911. [PubMed] [Google Scholar]
  • 12.Larsson A, Stephensen H, Wikkelsö C. [Normal pressure hydrocephalus. A condition of dementia, improved by shunt surgery] Lakartidningen. 1995;92:545–50. [PubMed] [Google Scholar]
  • 13.Neils DM, Wang H, Lin J. Endoscopic third ventriculostomy for shunt malfunction:What to do with the shunt? Surg Neurol Int. 2013;4:3. doi: 10.4103/2152-7806.106116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lam S, Harris D, Rocque BG, Ham SA. Pediatric endoscopic third ventriculostomy:A population-based study. J Neurosurg Pediatr. 2014;14:455–64. doi: 10.3171/2014.8.PEDS13680. [DOI] [PubMed] [Google Scholar]
  • 15.Drake JM Canadian Pediatric Neurosurgery Study Group. Endoscopic third ventriculostomy in pediatric patients:The Canadian experience. Neurosurgery. 2007;60:881–6. doi: 10.1227/01.NEU.0000255420.78431.E7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Family Medicine and Primary Care are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES